Filtered By:
Vaccination: Yellow Fever Vaccination
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 78 results found since Jan 2013.
4th Pediatric Allergy and Asthma Meeting (PAAM)
DISCUSSION SESSION 1: Food allergy (PD01 –PD05)PD01 Allergen-specific humoral and cellular responses in children who fail egg oral immunotherapy due to allergic reactionsMarta Vazquez-Ortiz, Mariona Pascal, Ana Maria Plaza, Manel JuanPD02 FoxP3 epigenetic features in children with cow milk allergyLorella Paparo, Rita Nocerino, Rosita Aitoro, Ilaria Langella, Antonio Amoroso, Alessia Amoroso, Carmen Di Scala, Roberto Berni CananiPD04 Combined milk and egg allergy in early childhood: let them eat cake?Santanu Maity, Giuseppina Rotiroti, Minal GandhiPD05 Introduction of complementary foods in relation to allergy and gut mic...
Source: Clinical and Translational Allergy - October 31, 2016 Category: Allergy & Immunology Source Type: research
Yellow Fever Vaccine (YFV) for Patients with Egg Allergy: Protocol Proposal.
The current yellow fever epidemic in Brazil has already 1,266 confirmed cases and 415 deaths by 2018-July. Vaccination is the most effective measure of protection against this disease. However, YFV shows ovalbumin levels (>2 μg/ml) not considered safe for patients with egg allergy (EA). Our objective was to describe the vaccination protocol using the Brazilian YFV in EA patients attended in a Reference Allergy Center and to relate the YFV skin tests (ST) to the clinical manifestations reported.
Source: Journal of Allergy and Clinical Immunology - February 1, 2019 Category: Allergy & Immunology Authors: Barbara Luiza B Cancado, Carolina S. Aranda, Alessandra R. Souza, Lily Y. Weckx, Marcia C. Mallozi, Dirceu Sole Source Type: research
Ovalbumin content in the yellow fever vaccine
Publication date: Available online 22 April 2015 Source:The Journal of Allergy and Clinical Immunology: In Practice Author(s): Derek Smith , Priscilla Wong , Robert Gomez , Kevin White
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 4, 2015 Category: Allergy & Immunology Source Type: research
Successful Administration of Yellow Fever Vaccine in Egg-allergic Patients
This study aims to describe the outcomes of yellow fever vaccination in patients with confirmed egg allergy (EA).
Source: Journal of Allergy and Clinical Immunology - February 1, 2019 Category: Allergy & Immunology Authors: Clarissa Morais Busatto Gerhardt, Gislane S. Juliao, Bruna Pultrini Aquilante, Cristiane N. Santos, Mayra de Barros Dorna, Antonio Carlos Pastorino, Ana Paula Moschione Castro Source Type: research
True, true, and unrelated: Stop routine testing to vaccine excipients for suspected vaccine allergy
Vaccines for infectious diseases contain multiple minor ingredients called excipients, such as egg ovalbumin, polysorbate (PS), polyethylene glycol (PEG), neomycin, thimerosal, and other contaminants (eg, lactose, yeast, formaldehyde, gelatin, latex).1,2 Allergic reactions occurring to vaccines are rare, but focus on vaccine excipients as the provoking cause.3 Examples of this include egg ovalbumin in yellow fever (YF), gelatin in measles, mumps, and rubella (MMR) and several other vaccines, yeast in hepatitis B vaccines, and casein with diphtheria tetanus acellular pertussis (DTaP).
Source: Annals of Allergy, Asthma and Immunology - June 16, 2022 Category: Allergy & Immunology Authors: Matthew Greenhawt Tags: Perspective Source Type: research
Egg allergy and yellow fever immunization: a safe desensitization plan
Yellow fever is a viral hemorrhagic disease with a high-mortality rate endemic to tropical regions of South America and sub-Saharan Africa. While the egg-derived yellow fever vaccine (YF-VAX, Sanofi Pasteur, USA) is safe and provides life-long protection, it can pose a challenge for egg-allergic patients living in or traveling to endemic areas.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: J. Zamora-Sifuentes, H. Niebur Tags: M045 Source Type: research
Egg allergy and yellow fever vaccination
CONCLUSION: There is a relationship between the positivity of the egg's components and the severity of the clinical reaction. Furthermore, the relationship between the positivity of the tests with the YFV and egg's components may show a tendency to look at ovomucoid and conalbumin, but it is not a certainty. Therefore, further studies are needed to confirm these associations, and for now, the authors still recommend using the vaccine for testing when necessary.PMID:37597532 | DOI:10.1016/j.jped.2023.07.004
Source: Jornal de Pediatria - August 19, 2023 Category: Pediatrics Authors: B árbara L B Cançado Carolina S Aranda Marcia C Mallozi Lily Y Weckx Dirceu Sol é Source Type: research
NIH launches early-stage yellow fever vaccine trial
( NIH/National Institute of Allergy and Infectious Diseases ) The National Institute of Allergy and Infectious has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus. The Phase 1 study is evaluating whether an experimental vaccine developed by the Danish biopharmaceutical company Bavarian Nordic is safe, tolerable and has the potential to prevent yellow fever virus infection.
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2016 Category: Infectious Diseases Source Type: news
